We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$513M
AUM Growth
-$74.9M
(-13%)
Cap. Flow
-$71.4M
Cap. Flow
% of AUM
-13.92%
Top 10 Holdings %
Top 10 Hldgs %
16.18%
Holding
249
New
34
Increased
44
Reduced
101
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$6.87M |
| 2 |
Magnolia Oil & Gas
MGY
|
+$6.85M |
| 3 |
Tidewater
TDW
|
+$6.69M |
| 4 |
CADE
Cadence Bank
CADE
|
+$6.45M |
| 5 |
Vita Coco
COCO
|
+$5.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SharkNinja
SN
|
+$9.45M |
| 2 |
Cohen & Steers
CNS
|
+$9.41M |
| 3 |
BWX Technologies
BWXT
|
+$8.27M |
| 4 |
STAG Industrial
STAG
|
+$6.59M |
| 5 |
PR
Permian Resources
PR
|
+$6.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.37% |
| 2 | Industrials | 16.17% |
| 3 | Financials | 14.84% |
| 4 | Consumer Discretionary | 13.64% |
| 5 | Technology | 13.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Biogen
BIIB
$30.7B
| – | – |
-2,901
| Closed | -$626K |
|
202
BioMarin Pharmaceuticals
BMRN
$12.4B
| – | – |
-7,049
| Closed | -$616K |
|
203
Braze
BRZE
$2.99B
| – | – |
-40,369
| Closed | -$1.79M |
|
204
Cigna
CI
$74.6B
| – | – |
-957
| Closed | -$348K |
|
205
Celldex Therapeutics
CLDX
$3.28B
| – | – |
-14,687
| Closed | -$616K |
|
|
206
Cohen & Steers
CNS
$4.3B
| – | – |
-122,345
| Closed | -$9.41M |
|
207
Cencora
COR
$61.2B
| – | – |
-1,056
| Closed | -$257K |
|
208
Walt Disney
DIS
$181B
| – | – |
-1,651
| Closed | -$202K |
|
209
DexCom
DXCM
$32B
| – | – |
-2,149
| Closed | -$298K |
|
210
Elevance Health
ELV
$85.5B
| – | – |
-528
| Closed | -$274K |
|
|
EXAS
211
DELISTED
Exact Sciences
EXAS
| – | – |
-6,059
| Closed | -$418K |
|
212
Gilead Sciences
GILD
$165B
| – | – |
-5,858
| Closed | -$429K |
|
213
Helen of Troy
HELE
$693M
| – | – |
-51,518
| Closed | -$5.94M |
|
214
Incyte
INCY
$24.4B
| – | – |
-5,433
| Closed | -$310K |
|
215
Iovance Biotherapeutics
IOVA
$2.87B
| – | – |
-224,831
| Closed | -$3.33M |
|
216
IQVIA
IQV
$39.3B
| – | – |
-1,878
| Closed | -$475K |
|
217
Intuitive Surgical
ISRG
$134B
| – | – |
-700
| Closed | -$279K |
|
218
Illinois Tool Works
ITW
$84.5B
| – | – |
-782
| Closed | -$210K |
|
219
Jazz Pharmaceuticals
JAZZ
$16.7B
| – | – |
-1,755
| Closed | -$211K |
|
220
Kinsale Capital Group
KNSL
$8.51B
| – | – |
-1,573
| Closed | -$825K |
|
221
McDonald's
MCD
$195B
| – | – |
-1,086
| Closed | -$306K |
|
222
McKesson
MCK
$101B
| – | – |
-473
| Closed | -$254K |
|
223
Medpace
MEDP
$16.5B
| – | – |
-1,110
| Closed | -$449K |
|
224
Neurocrine Biosciences
NBIX
$16.6B
| – | – |
-4,863
| Closed | -$671K |
|
225
Nextpower Inc
NXT
$15.7B
| – | – |
-86,679
| Closed | -$4.88M |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Moody Aldrich Partners held 249 positions worth $513M, down 13% from $588M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Moody Aldrich Partners withdrew a net $71.4M in Q2 2024, closing 55 positions and reducing 101 holdings. Its most notable exit was Cohen & Steers, an estimated $9.41M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
Against the trend, Moody Aldrich Partners opened a new position in Intra-Cellular Therapies Inc. worth $6.78M.
- Moody Aldrich Partners's largest Q2 2024 buy was Intra-Cellular Therapies Inc.: 99,012 shares worth $6.78M.
- Moody Aldrich Partners added most to Crinetics Pharmaceuticals in Q2 2024, an estimated $4.33M increase.
- Moody Aldrich Partners's biggest Q2 2024 reduction was SharkNinja, cutting an estimated $9.45M.
- Moody Aldrich Partners fully exited Cohen & Steers in Q2 2024, selling an estimated $9.41M.
- Moody Aldrich Partners's ten largest holdings make up 16% of its $513M portfolio in Q2 2024.
- Moody Aldrich Partners opened 34 new positions and closed 55 in Q2 2024.
- Moody Aldrich Partners's portfolio value fell 13% quarter-over-quarter to $513M.
Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.